18. Cells Can Feel Their Environment Absurd Health Institute | Medical Concept Papers, Volume Four | IV. The tissue remembers Publication type: Revised medical concept and hypothesis essay — not peer reviewed Corrective edition: 17 October 2026 Substantive text: 1,255 words Abstract Cells detect substrate stiffness, shear force and matrix organization through mechanotransduction. These signals alter gene expression and phenotype, offering a route by which altered tissue architecture becomes a biological cause rather than a passive consequence. Cells detect substrate stiffness, shear force and matrix organization through mechanotransduction. These signals alter gene expression and phenotype, offering a route by which altered tissue architecture becomes a biological cause rather than a passive consequence. Chemistry is not the only language of a tissue A cell encounters growth factors and metabolites, but it also experiences tension, confinement, flow and the resistance of its surroundings. Integrins and associated complexes connect extracellular matrix to the cytoskeleton. Actomyosin contraction probes mechanical resistance, and transcriptional regulators such as YAP/TAZ respond to combinations of physical and biochemical inputs. Tissue mechanics can therefore influence proliferation, differentiation, migration and survival. An experimental route from material to behavior In culture, the same cell type can behave differently on substrates of different stiffness. Work on fibrotic lung tissue shows increased YAP/TAZ activity within stiff regions and altered fibroblast activity when those pathways are manipulated in experimental conditions. This is direct evidence that mechanics can shape cellular programs. It does not follow that mechanical inputs explain all epigenetic or metabolic abnormalities. Why this matters to chronic disease Fibrosis can make tissue stiff; increased stiffness can reinforce fibroblast activation. Tumor cells and immune cells also interact with varied mechanical environments. Distorted matrix may compress small vessels or interfere with repair. Such loops link anatomy and molecular signaling across scales. The contribution of this paper is to show precisely how 'environment' can mean something measurable, rather than a nonspecific collection of presumed toxins or stresses. Important limits of the model Not every organ responds identically to stiffness. Cells integrate many inputs, and different pathways dominate in different tissues. A local mechanical abnormality does not prove a systemic disease mechanism. Furthermore, an observed correlation between stiffness and adverse outcomes could reflect accumulated tissue damage rather than a modifiable driving signal. A discriminating prediction If mechanics actively maintains a disease, restoring normal matrix mechanical properties—while leaving other inputs similar—should alter key cell behaviors or tissue function. Experimental perturbation strengthens causal inference more than comparing soft and scarred patient tissues. Human translation should privilege validated treatments and avoid promising tissue 'reprogramming' from untested external modalities. Mechanobiology gives form to the word environment In many discussions of terrain, 'environment' is used loosely to mean diet, chemicals, stress or microbiota. Matrix mechanics is different because the relevant conditions can be defined in physical units and manipulated in experiments. Substrate stiffness, stretch, shear and tissue tension can be measured, and cells can be studied under controlled conditions. The framework thereby produces potentially falsifiable hypotheses rather than merely asserting that surroundings influence health. Chemical and mechanical signals interact A stiffened matrix may change the cellular response to a growth factor; inflammatory cytokines can change cytoskeletal organization; changes in blood flow can influence endothelial behavior. These reciprocal relationships help explain why targeting one biochemical node sometimes produces variable outcomes. Yet complexity should not be used as an excuse for vague causal claims. Which molecule, which physical force, which cell and which outcome remain the necessary questions. A tissue-specific clinical implication Research on fibrotic lung or tumor stroma can inform mechanistic thinking, but human therapeutic translation remains uncertain. A patient with back pain should not be told that their extracellular matrix is mechanically 'programmed' without a defensible diagnosis. The important promise is improved disease models and perhaps better treatments, not a new universal somatic diagnosis. Mechanical force is a form of biological input Cells sense the properties of their physical surroundings through receptors and structural connections linking extracellular matrix to the cytoskeleton. Integrins, focal adhesions, actomyosin tension and nuclear signaling can translate force into changes in gene expression and cell behavior. YAP and TAZ are among the studied mediators of this response, although they also participate in pathways that do not reduce simply to stiffness. It is therefore plausible for two genetically similar cells to behave differently when placed on matrices with different mechanical properties. This observation has implications for healing. An epithelial cell migrating across an injury, a fibroblast encountering newly deposited collagen, and a stem cell within an aging niche may each receive different physical instructions. But the physical context is multidimensional: substrate stiffness, fiber alignment, shear stress, stretch, cell density and ligand presentation can change simultaneously. Experiments that alter several variables at once cannot attribute a response to stiffness alone. The danger of interpreting mechanical research too broadly A laboratory result showing that fibroblasts activate on stiff gels cannot prove that a patient's chronic pain comes from 'tight fascia.' Local pain can involve peripheral nerve damage, central sensitization, inflammation, muscle loading and psychosocial factors. Measured tissue stiffness may be an effect of injury, an adaptation to loading or a contributor to symptoms. Without objective localization and appropriate comparators, invoking mechanotransduction adds vocabulary rather than explanation. The same issue appears in cancer biology. Matrix stiffness can affect cell migration and signaling, but malignant mutations, immune evasion and tissue-specific ecology remain central to tumor development. Changing matrix mechanics in a model may alter tumor behavior without proving that mechanical therapy is an effective cancer treatment. Mechanistic leverage and clinical benefit are different claims. A genuinely informative experimental comparison Investigators might isolate the relevant fibroblast subtype and culture it on matrices matched for biochemical composition but varied systematically in stiffness. They could assess myofibroblast markers, collagen production and YAP/TAZ localization, then repeat the experiment in three-dimensional tissue models. Next they would examine whether an observed response also appears in human disease samples, and finally whether altering that pathway changes tissue function. This progression helps prevent a culture observation from being advertised as a therapeutic conclusion. The terrain concept becomes productive when it describes the extracellular environment as a source of measurable physical information. It becomes misleading when 'energy,' 'tension' or 'environment' is invoked without defining the force, receptor, timescale or functional consequence. Cells can indeed feel their surroundings; demonstrating which sensation matters in a particular disease is the scientific challenge. Mechanical experiments require realistic comparisons Culture models often use flat, uniformly stiff substrates, whereas real tissues present three-dimensional fibers, variable ligand density, cyclic forces and multiple cell types. A response observed on a plastic dish may be an exaggerated version of physiological mechanosensing. Researchers can improve translation with three-dimensional matrices, organoids and controlled loading systems, but even those models have limits. A clinically relevant theory ultimately needs evidence from diseased human tissue or a validated disease model rather than a striking image of altered cell shape. An additional causal complication is that cells actively remodel their substrate. The matrix that appears to drive fibroblast activation may have been stiffened by those very cells. To establish direction, experiments should alter matrix mechanics independently of cell-produced collagen when feasible, and separately manipulate cell contractility. If both directions are supported, a reinforcing loop becomes plausible. If changes in stiffness are entirely secondary, reducing them may not modify the underlying disease. The possibility of such a negative result is what makes the mechanical hypothesis scientifically testable. Why mechanical exposure is clinically contextual The stiffness and stretch experienced by a cell change during normal exercise, breathing and wound contraction. Not every activation of a mechanosensitive pathway is pathological. The same transcriptional factor may help ordinary adaptation in one context while contributing to fibrosis in another. To make an intervention claim, investigators should identify whether the relevant signal is excessive, mistimed or occurring in a vulnerable tissue. They should also show that suppressing it does not impair normal repair. Otherwise, a plausible mechanistic target risks being promoted as a universal treatment without a valid clinical indication. Selected scientific reading 1. Liu F et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015. (https://pubmed.ncbi.nlm.nih.gov/25502501/) 2. Dupont S. Role of YAP/TAZ in cell-matrix adhesion-mediated signalling and mechanotransduction. Exp Cell Res. 2016;343:42–53. (https://doi.org/10.1016/j.yexcr.2015.10.034) Editorial and evidentiary note This is an expanded conceptual synthesis, not original clinical research or a clinical treatment protocol. It preserves selected references from the original edition, whose bibliographic metadata have not all been independently reverified. Claims about specific diagnoses and treatments require appropriate primary evidence and professional assessment. Mechanistic plausibility does not establish therapeutic efficacy.